PAVmed Inc. (PAVM)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| — | 8-K (2026-05-15) · 99.1 | |||
| 10-QLatest | Q1-2026 | 8-K (2026-03-30) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2025-11-13) · 99.1 | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | 8-K (2025-03-25) · 99.1 | ||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | 8-K (2024-08-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | 8-K (2023-11-15) · 99.1 | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Statements | ||
| Condensed Consolidated Balance Sheets (current Period Unaudited) | — |
|
| Consolidated Balance Sheets | ||
| Condensed Consolidated Balance Sheets (current Period Unaudited) (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statement of Changes In Equity (deficit) (unaudited) | — |
|
| Consolidated Statement of Changes In Stockholders' Equity (deficit) | ||
| Consolidated Statements of Operations (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses and Other Current Liabilities | — |
|
| Asset Purchase Agreement and Management Services Agreement | ||
| Award Timing Disclosure | — |
|
| Commitment and Contingencies | ||
| Common Stock and Common Stock Purchase Warrants | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Equity Method Investment | ||
| Financial Instruments Fair Value Measurements | ||
| Fixed Assets | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets, Net | ||
| Leases | ||
| Liquidity and Going Concern | ||
| Net Income (loss) Per Share | ||
| Net Loss Per Share | ||
| Noncontrolling Interest | ||
| Note 1 | ||
| Note 10 | ||
| Note 11 | ||
| Note 12 | ||
| Note 13 | ||
| Note 14 | ||
| Note 15 | ||
| Note 16 | — |
|
| Note 17 | — |
|
| Note 18 | — |
|
| Note 19 | — |
|
| Note 2 | ||
| Note 3 | ||
| Note 4 | ||
| Note 5 | ||
| Note 6 | ||
| Note 7 | ||
| Note 8 | ||
| Note 9 | ||
| Pay Vs Performance Disclosure | ||
| Preferred Stock | ||
| Prepaid Expenses, Deposits, and Other Current Assets | ||
| Recent Accounting Standards Updates Not Yet Adopted | — |
|
| Related Party Transactions | — |
|
| Revenue From Contracts With Customers | ||
| Segment Information | ||
| Stock-based Compensation | ||
| Summary of Significant Accounting Policies | ||
| The Company | ||